Clinical Outcome after Selective Treatment of Patients Diagnosed with Ductal Carcinoma In Situ of the Breast
Authors:
- 7 November 2007
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 15 (1) , 235-243
Abstract
Background The effect of treatment of patients diagnosed with ductal carcinoma in situ (DCIS) of the breast was evaluated, and factors associated with local recurrence were assessed.Keywords
This publication has 20 references indexed in Scilit:
- Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma-In-Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853—A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy GroupJournal of Clinical Oncology, 2006
- Impact of estrogen receptor expression and other clinicopathologic features on tamoxifen use in ductal carcinoma in situCancer, 2006
- The natural history of low‐grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long‐term follow‐upCancer, 2005
- Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trialThe Lancet, 2003
- Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast CancerNew England Journal of Medicine, 2002
- Detection of Ductal Carcinoma In Situ in Women Undergoing Screening MammographyJNCI: Journal of the National Cancer Institute, 2002
- Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCISBritish Journal of Cancer, 2002
- Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional RadiationNew England Journal of Medicine, 2001
- Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experienceSeminars in Oncology, 2001
- Risk Factors for Recurrence and Metastasis After Breast-Conserving Therapy for Ductal Carcinoma-In-Situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853Journal of Clinical Oncology, 2001